
Alta Life Sciences
Overview
Multistage venture capital firm investing in life sciences companies.
Founded
2016
Deals · 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Ona Therapeutics | Jun 2026Participated | $87 MSeries B | |
DeepUll | Oct 2022Participated | $13 MSeries B | |
Mediktor | Oct 2021Participated | $13 MOther Equity | |
Binx Health | May 2021Participated | $104 MSeries E | |
INBRAIN Neuroelectronics | Mar 2021Led | $17 MSeries A | |
Peptomyc | Dec 2020Participated | $14 MOther Equity | |
Binx | Nov 2020Led | $13 MOther Equity | |
DeepUll | Jul 2020Led | $4 MSeries A | |
Ona Therapeutics | Jun 2020Participated | $34 MSeries A | |
INBRAIN Neuroelectronics | Jun 2020Led | $1 MOther Equity | |
Accure Therapeutics | May 2020Led | $8 MOther Equity | |
SANIFIT | Jun 2019Participated | $82 MSeries D | |
Ona Therapeutics | Jun 2026Participated | $87 MSeries B | |
DeepUll | Oct 2022Participated | $13 MSeries B | |
Mediktor | Oct 2021Participated | $13 MOther Equity | |
Binx Health | May 2021Participated | $104 MSeries E | |
INBRAIN Neuroelectronics | Mar 2021Led | $17 MSeries A | |
Peptomyc | Dec 2020Participated | $14 MOther Equity | |
Binx | Nov 2020Led | $13 MOther Equity | |
DeepUll | Jul 2020Led | $4 MSeries A | |
Ona Therapeutics | Jun 2020Participated | $34 MSeries A | |
INBRAIN Neuroelectronics | Jun 2020Led | $1 MOther Equity | |
Accure Therapeutics | May 2020Led | $8 MOther Equity | |
SANIFIT | Jun 2019Participated | $82 MSeries D |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 5 | 1 |
| Series B | 0 | 2 |
| Series C+ | 0 | 2 |
| Other Equity | 3 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '17 | 1 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 1 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 1 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 1 |
| Jun '20 | 2 |
| Jul '20 | 1 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 1 |
| Dec '20 | 1 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 1 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 1 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 1 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 14 |
| Networks, Cloud & Communication | 2 |
| AI & Machine Learning | 2 |
| Space & Frontier Tech | 2 |
| Enterprise Software | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 4 |
| $5M-$10M | 2 |
| $10M-$25M | 5 |
| $25M-$50M | 1 |
| $50M-$100M | 2 |
| $100M-$250M | 1 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Europe | 13 |
| United States | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Asabys Partners | 4 |
| CDTI | 3 |
| HealthEquity | 3 |
| Ysios Capital | 3 |
| Axis Participaciones Empresariales | 2 |
| Bpifrance | 2 |
| Columbus Venture Partners | 2 |
| EQT Life Sciences (LSP) | 2 |
| Fund+ | 2 |
| Johnson & Johnson Innovation | 2 |
| Kurma Partners | 2 |
| Andera Partners | 1 |
| ArrowMark Partners | 1 |
| AurorA Science | 1 |
| Business Angels | 1 |
| Caixa Capital Risc | 1 |
| Castel Capital | 1 |
| CDTI Innvierte | 1 |
| COFIDES | 1 |
| Forbion | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 8 | 53% |
| Participating | 7 | 47% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 5 | 63% |
| Co-led | 3 | 38% |
Team
Managing General Partner
Partner
General Partner
General Partner
General Partner